Target intelligence / Profile preview

RNA, U2 small nuclear 40, pseudogene (RNU2-40P)

Target
RNU2-40P
Molecular classification
Other, Pseudogene, Small nuclear RNA pseudogene
01

Overview

RNU2-40P (RNA, U2 small nuclear 40, pseudogene) is a non-coding RNA pseudogene that derives from the U2 small nuclear RNA (snRNA) gene family[1]. U2 snRNA itself is an essential component of the spliceosome and plays a critical role in pre-mRNA splicing; however, as a pseudogene, RNU2-40P does not produce a functional RNA product and has no known biological function, protein product, or therapeutic relevance[1]. There are no documented roles in disease, drug interactions, or biomarker applications for this pseudogene variant. Context: - The “U2 small nuclear RNA” family (e.g., RNU2-2, RNU2-40P) is a group of RNAs involved in the essential function of splicing, but only the bona fide (functional) U2 genes carry out biological functions[2][3][4]. - The “pseudogene” status indicates RNU2-40P is a non-functional, inactive genomic copy and is not a receptor, enzyme, drug target, or biomarker. - No publications or databases describe RNU2-40P as implicated in disease or as a therapeutic target[1]. This conforms to the conventions requested: using the correct name, accurate molecular classification ("Pseudogene" or "Other"), and reporting null for all disease- or drug-related information.

Other names
RNU2-40PRNA, U2 small nuclear 40, pseudogene

Beyond the preview

Go deeper on RNA, U2 small nuclear 40, pseudogene (RNU2-40P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 40, pseudogene (RNU2-40P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call